RCT to compare (PPH) plus (LA) with (PPH) in treatment of grade III and IV hemorroidal

RCT to compare stapled hemorroidopexy (PPH) plus ligation anopexy (LA) with stapled hemorroidepexy (PPH) in treatment of grade III and IV hemorroidal disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201801002931307

Enrollment

100

Registered

2018-01-02

Start date

2018-01-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System hemorroidal disease

Interventions

Stapler haemorrhoidopexy

Stapler haemorrhoidopexy plus ligation anopexy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: grade III and IV hemorrhoids requiring hemorrhoidectomy.

Exclusion criteria

Exclusion criteria: ¿ first and second degree hemorrhoids ¿ patients with firm and fibrotic external irreducible haemorrhoids thrombosed hemorrhoids; recurrent hemorrhoids after previous surgical treatment history of inflammatory bowel disease; history of colon, rectal or anal cancer inability to give informed consent age < 18 years pregnant women.

Design outcomes

Primary

Measure	Time frame
Symptoms Remission Rate	—

Secondary

Measure	Time frame
Operative time;Postoperative mobilization time ;Onset of oral feeding ;Postoperative pain level at 12 hours ;Hypotension;Nausea;Vomiting;Headache;Urinary retention;Bleeding at the operative site;Postoperative discharge time ;Postoperative pain level at 7 days;Oedema at the operative site ;Hematoma at the operative site;Infection at the operative site ;Stenosis at the operative site;Postoperative return to work time;Pruritus ;Mucosal prolpase;Mucosal prolapse ;Perianal nodules;Constipation ;Tenesmus;Reoperation;Disease recurrence rate;Satisfaction level;Difference in the quality of life of the patient	—

Measure

Time frame

Operative time;Postoperative mobilization time ;Onset of oral feeding ;Postoperative pain level at 12 hours ;Hypotension;Nausea;Vomiting;Headache;Urinary retention;Bleeding at the operative site;Postoperative discharge time ;Postoperative pain level at 7 days;Oedema at the operative site ;Hematoma at the operative site;Infection at the operative site ;Stenosis at the operative site;Postoperative return to work time;Pruritus ;Mucosal prolpase;Mucosal prolapse ;Perianal nodules;Constipation ;Tenesmus;Reoperation;Disease recurrence rate;Satisfaction level;Difference in the quality of life of the patient

—

Countries

Egypt

Contacts

Public ContactIsraa aly

ethical committee director

israa.aly@alexmed.edu.eg00212287740750

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026